Correlation Between Humacyte and Aclarion
Can any of the company-specific risk be diversified away by investing in both Humacyte and Aclarion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and Aclarion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humacyte and Aclarion, you can compare the effects of market volatilities on Humacyte and Aclarion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of Aclarion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and Aclarion.
Diversification Opportunities for Humacyte and Aclarion
Significant diversification
The 3 months correlation between Humacyte and Aclarion is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and Aclarion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclarion and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with Aclarion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclarion has no effect on the direction of Humacyte i.e., Humacyte and Aclarion go up and down completely randomly.
Pair Corralation between Humacyte and Aclarion
Assuming the 90 days horizon Humacyte is expected to generate 22.6 times less return on investment than Aclarion. But when comparing it to its historical volatility, Humacyte is 13.56 times less risky than Aclarion. It trades about 0.07 of its potential returns per unit of risk. Aclarion is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Aclarion on September 1, 2024 and sell it today you would earn a total of 0.90 from holding Aclarion or generate 30.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 74.47% |
| Values | Daily Returns |
Humacyte vs. Aclarion
Performance |
| Timeline |
| Humacyte |
| Aclarion |
Humacyte and Aclarion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Humacyte and Aclarion
The main advantage of trading using opposite Humacyte and Aclarion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, Aclarion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will offset losses from the drop in Aclarion's long position.The idea behind Humacyte and Aclarion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Aclarion vs. Aclarion | Aclarion vs. Iveda Solutions Warrant | Aclarion vs. Heartbeam Warrant | Aclarion vs. Edible Garden AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |